Skip to content
10-Q

Quarterly Report

REATA PHARMACEUTICALS INC

0000950170-22-022879

← back to feed
Filed
Nov 8, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2022 · Sep 30, 2022 36.54M sh
Shares Diluted Q3 2022 · Sep 30, 2022 36.47M sh
Shares Diluted Q3 2022 · Sep 30, 2021 36.39M sh
Shares Diluted Q3 2022 · Sep 30, 2021 36.3M sh
Capex Q3 2022 · Sep 30, 2022 $2.9M
Capex Q3 2022 · Sep 30, 2021 $1.14M
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$153.84M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$112.77M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $31.92M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $590.26M
Stockholders Equity Q3 2022 · Sep 30, 2022 $4.52M
Stockholders Equity Q3 2022 · Jun 30, 2022 $68.64M
Stockholders Equity Q3 2022 · Dec 31, 2021 $185.99M
Stockholders Equity Q3 2022 · Sep 30, 2021 $255.98M
Stockholders Equity Q3 2022 · Jun 30, 2021 $313.83M
Stockholders Equity Q3 2022 · Dec 31, 2020 $417.43M
Current Liabilities Q3 2022 · Sep 30, 2022 $50.71M
Current Liabilities Q3 2022 · Dec 31, 2021 $53.99M
Current Assets Q3 2022 · Sep 30, 2022 $445.1M
Current Assets Q3 2022 · Dec 31, 2021 $596.48M
Total Assets Q3 2022 · Sep 30, 2022 $583.64M
Total Assets Q3 2022 · Dec 31, 2021 $735.02M
Eps Diluted Q3 2022 · Sep 30, 2022 −$2.16
Eps Diluted Q3 2022 · Sep 30, 2022 −$6.21
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.97
Eps Diluted Q3 2022 · Sep 30, 2021 −$5.84
Eps Basic Q3 2022 · Sep 30, 2022 −$2.16
Eps Basic Q3 2022 · Sep 30, 2022 −$6.21
Eps Basic Q3 2022 · Sep 30, 2021 −$1.97
Eps Basic Q3 2022 · Sep 30, 2021 −$5.84
Rd Expense Q3 2022 · Sep 30, 2022 $43.49M
Rd Expense Q3 2022 · Sep 30, 2022 $122.62M
Rd Expense Q3 2022 · Sep 30, 2021 $39.43M
Rd Expense Q3 2022 · Sep 30, 2021 $114.38M
Net Income Q3 2022 · Sep 30, 2022 −$79M
Net Income Q3 2022 · Sep 30, 2022 −$226.4M
Net Income Q3 2022 · Sep 30, 2021 −$71.85M
Net Income Q3 2022 · Sep 30, 2021 −$212M
Revenue Q3 2022 · Sep 30, 2022 $540K
Revenue Q3 2022 · Sep 30, 2022 $2.22M
Revenue Q3 2022 · Sep 30, 2021 $7.39M
Revenue Q3 2022 · Sep 30, 2021 $10.56M